Currently out of the existing stock ratings of Jason Wittes, 79 are a BUY (85.87%), 13 are a HOLD (14.13%).

Jason Wittes

Work Performance Price Targets & Ratings Chart

Analyst Jason Wittes, carries an average stock price target met ratio of 42.92% that have a potential upside of 26.92% achieved within 121 days. Previously, Jason Wittes worked at NORTHLAND CAPITAL MARKETS, AEGIS, BREAN.

Jason Wittes’s has documented 171 price targets and ratings displayed on 20 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on SYK, Stryker at 02-May-2025.

Wall Street Analyst Jason Wittes

Analyst best performing recommendations are on PGNX (PROGENICS PHARMACEUTICALS).
The best stock recommendation documented was for BWAY (BRAINSWAY LTD) at 8/10/2023. The price target of $5.5 was fulfilled within 104 days with a profit of $2.8 (103.7%) receiving and performance score of 9.97.

Average potential price target upside

of $41.82 (18.27%) on SYK (STRYKER).
of $18.58 (17.46%) on TFX (TELEFLEX).
of $14.64 (12.06%) on ZBH (ZIMMER BIOMET HOLDINGS).

ARAY Accuray ATEC Alphatec Holdings GMED Globus Medical STXS Stereotaxis SYK Stryker TFX Teleflex ZBH Zimmer Biomet Holdings VAR Varian Medical Systems BWAY Brainsway Ltd NUVA NuVasive NVCR Novocure Ltd MASI Masimo CLDX Celldex Therapeutics LMAT LeMaitre Vascular MDWD Mediwound Ltd PGNX Progenics Pharmaceuticals ENOV Enovis Corp OFIX Orthofix Medical IRMD Iradimed Co TLSI TriSalus Life Sciences

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Jason Wittes (LOOP CAPITAL)